v3.26.1
Investments (Details 3) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Schedule of Investments [Line Items]        
Fair value, beginning of period [1],[2],[3]     $ 132,220,501  
Fair value, end of period [4],[5],[6] $ 157,635,546   157,635,546  
Non Controlled/Affiliated Investments [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 46,797,134 $ 12,881,904 40,823,403 $ 12,881,904
Gross Additions 16,001,604 10,999,999 21,001,604 10,999,999
Gross Reductions (211,086) [7] 0 (211,086) [7] 0
Change in Unrealized Gains (Losses) 7,035,182 5,258,899 8,008,913 5,258,899
Fair value, end of period 69,622,834 [4],[6] 29,140,802 69,622,834 [4],[6] 29,140,802
Dividend and Interest Income 127,300 0 163,887 0
Non Controlled/Affiliated Investments [Member] | ChartSpan Medical Technologies, Inc. [Member] | Preferred Stock Investments [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 19,553,113 0 20,533,093 0
Gross Additions 16,001,604 6,999,999 16,001,604 6,999,999
Gross Reductions 0 [7] 0 0 [7] 0
Change in Unrealized Gains (Losses) 2,646,546 2,607,369 1,666,566 2,607,369
Fair value, end of period 38,201,263 9,607,368 38,201,263 9,607,368
Dividend and Interest Income 1,604 0 1,604 0
Non Controlled/Affiliated Investments [Member] | Integrative Life Network, LLC [Member] | Common Stock Investments [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 211,086 796,904 341,733 796,904
Gross Additions 0 0 0 0
Gross Reductions (211,086) [7] 0 (211,086) [7] 0
Change in Unrealized Gains (Losses) 0 (488,819) (130,647) (488,819)
Fair value, end of period 0 308,085 0 308,085
Dividend and Interest Income 0 0 0 0
Non Controlled/Affiliated Investments [Member] | Istios Health, LLC [Member] | Preferred Stock Investments [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 4,000,000 0 4,000,000 0
Gross Additions 0 4,000,000 0 4,000,000
Gross Reductions 0 [7] 0 0 [7] 0
Change in Unrealized Gains (Losses) 3,143,933 0 3,143,933 0
Fair value, end of period 7,143,933 4,000,000 7,143,933 4,000,000
Dividend and Interest Income 0 0 0 0
Non Controlled/Affiliated Investments [Member] | Korio Inc [Member] | Preferred Stock Investments [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 3,931,219 3,500,000 3,777,486 3,500,000
Gross Additions 0 0 0 0
Gross Reductions 0 [7] 0 0 [7] 0
Change in Unrealized Gains (Losses) 191,742 0 345,475 0
Fair value, end of period 4,122,961 3,500,000 4,122,961 3,500,000
Dividend and Interest Income 0 0 0 0
Non Controlled/Affiliated Investments [Member] | Korio Inc [Member] | Unsecured Convertible Notes [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 2,000,000   0  
Gross Additions 0   2,000,000  
Gross Reductions [7] 0   0  
Change in Unrealized Gains (Losses) 0   0  
Fair value, end of period 2,000,000   2,000,000  
Dividend and Interest Income 49,863   75,616  
Non Controlled/Affiliated Investments [Member] | Peregrine Health, Inc. [Member] | Preferred Stock Investments [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 12,528,408 8,083,176 10,955,748 8,083,176
Gross Additions 0 0 0 0
Gross Reductions 0 [7] 0 0 [7] 0
Change in Unrealized Gains (Losses) 829,539 2,483,330 2,402,199 2,483,330
Fair value, end of period 13,357,947 10,566,506 13,357,947 10,566,506
Dividend and Interest Income 0 0 0 0
Non Controlled/Affiliated Investments [Member] | Peregrine Health, Inc. [Member] | Warrant [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 1,573,308 501,824 1,215,343 501,824
Gross Additions 0 0 0 0
Gross Reductions 0 [7] 0 0 [7] 0
Change in Unrealized Gains (Losses) 223,422 657,019 581,387 657,019
Fair value, end of period 1,796,730 1,158,843 1,796,730 1,158,843
Dividend and Interest Income 0 $ 0 0 $ 0
Non Controlled/Affiliated Investments [Member] | Peregrine Health, Inc. [Member] | Unsecured Convertible Notes [Member]        
Schedule of Investments [Line Items]        
Fair value, beginning of period 3,000,000   0  
Gross Additions 0   3,000,000  
Gross Reductions [7] 0   0  
Change in Unrealized Gains (Losses) 0   0  
Fair value, end of period 3,000,000   3,000,000  
Dividend and Interest Income $ 75,833   $ 86,667  
[1] All investments are domiciled in the United States unless otherwise noted.
[2] Securities exempt from registration under the Securities Act (as defined in Note 1), and are deemed to be “restricted securities”. As of December 31, 2025, the aggregate fair value of these securities is $132.2 million or 84.4% of the Company’s net assets.
[3] Unless otherwise indicated, these investments were valued using unobservable inputs and are considered Level 3 investments.
[4] All investments are domiciled in the United States unless otherwise noted.
[5] Securities exempt from registration under the Securities Act (as defined in Note 1), and are deemed to be “restricted securities”. As of June 30, 2026, the aggregate fair value of these securities is $157.6 million or 89.2% of the Company’s net assets.
[6] Unless otherwise indicated, these investments were valued using unobservable inputs and are considered Level 3 investments.
[7] The "Gross Reductions" column represents the net change in investment classification from non-controlled/affiliated to non-controlled/non-affiliated at the time of transfer.